Ebix Q3 Revenues Increase 39% Sequentially and 5% Year-Over-Year
Ebix reported strong Q3 2020 results despite COVID-19 impacts, achieving revenues of $154.3 million, a 39% increase from Q2 2020 and a 5% increase year-over-year. GAAP operating income rose to $31.9 million and diluted EPS reached $0.80. The company generated $71.8 million in operating cash flow year-to-date. The diversity in revenue sources and robust demand for payment solutions helped drive performance, even as sectors like travel and forex struggled. However, there is uncertainty in guidance due to ongoing market disruptions.
- Q3 2020 revenue of $154.3 million, a 39% increase over Q2 2020.
- GAAP operating income increased by 23% to $31.9 million compared to Q3 2019.
- Non-GAAP diluted EPS of $0.93, showing resilience amid COVID-19 challenges.
- Year-to-date operating cash flow reached $71.8 million, an 18% increase from 2019.
- Revenue from travel, forex, e-learning and remittance businesses significantly declined due to COVID-19 impacts.
- Insurance exchange revenue down 11% year-over-year, indicating challenges in core operations.
• Q3 Operating Income of
• Year-to-date operating cash flow of
JOHNS CREEK, Ga., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Ebix, Inc. (NASDAQ: EBIX), today announced the following results for the quarter ended September 30, 2020:
- Diluted EPS (GAAP) of
$0.80 and Non-GAAP diluted EPS of$0.93 - Revenues of
$154.3 million and constant currency revenues of$160.2 million - GAAP operating income of
$31.9 million and Non-GAAP operating income of$35.8 million
Ebix will host a conference call to review its results today at 11:00 a.m. EDT (details below).
Ebix Chairman, President and CEO Robin Raina said, “In spite of the continued impact of COVID-19 across several major areas of our global operations, we are reporting Q3 2020 revenues of
Ebix delivered the following results for the third quarter of 2020:
Revenue: Q3 2020 revenue increased
On a constant currency basis, Ebix Q3 2020 revenues would have been
(dollar amounts in thousands) | |||||||||||
Channel | Q3 2020 | Q3 2019 | Change | YTD 2020 | YTD 2019 | Change | |||||
EbixCash Exchanges | - | ||||||||||
Insurance Exchanges | 42,382 | 47,385 | - | 129,342 | 141,993 | - | |||||
RCS – Insurance | 15,151 | 17,763 | - | 46,284 | 53,669 | - | |||||
Total Revenue | - | ||||||||||
Total Revenue on Constant Currency Basis | - |
Operating Income and Operating Cash: Q3 2020 GAAP operating income increased
On a year-to-date basis, cash generated from operations at 30th September 2020 was
Earnings per Share: In spite of the impact of COVID-19, Q3 2020 GAAP diluted earnings per share was
Net Income: Q3 2020 GAAP net income increased
Shares Outstanding and Repurchases: In Q3 2020, Ebix made no repurchases of its outstanding common stock. Ebix’s weighted average diluted shares outstanding was 30.9 million in Q3 2020 compared to 30.6 million in Q3 2019 and 30.7 million in Q2 2020.
Q4 2020 Diluted Share Count: As of today, Ebix expects its diluted share count for Q4 2020 to be approximately 30.9 million.
Dividend: Ebix paid its regular quarterly dividend of
Ebix Chairman, President and CEO Robin Raina said, “Ebix has a track record of two decades of consistency in terms of the key financial metrics of top line, operating income, EPS and cash flows, with a strong focus on operating margins. In the last few quarters, we adjusted our strategy to counter the impact of COVID-19 and focused our energies on organic growth in areas that were not impacted materially by COVID-19, while trying to protect operating margins in core business areas. We are pleased that we were successful in our strategy as reflected by our revenue growth, operating income and operating cash flows. We grew our overall revenues
Steve Hamil, EVP and Global CFO added, “The Company continues to produce robust operating cash flows, generating $
2020 Business Outlook: Given the ongoing market disruption caused by the COVID-19 pandemic, and related uncertainty on timing and extent of recovery, the Company is not providing fiscal 2020 or 2021 revenue and earnings guidance at this time.
Reconciliation of EBITDA, GAAP net income and diluted earnings per share to non-GAAP net income and diluted earnings per share. Non-GAAP information is provided to enhance the understanding of the Company's financial performance and is reconciled to the Company's GAAP information in the accompanying tables.
Q3 2020
(dollar amounts in thousands except EPS) | Diluted EPS | |||||
Q3 2020 GAAP Net Income | ||||||
Q3 2020 GAAP Operating Income | ||||||
Non-GAAP Adjustments: | ||||||
Amortization of Intangibles (1) | ||||||
Stock-Based Compensation (1) | ||||||
One-Time Legal Costs (2) | ||||||
Income Tax Effects of Non-GAAP adjustments (3) | ( | ) | ( | ) | ||
Total Non-GAAP Adjustments (Operating Income) | ||||||
Total Non-GAAP Adjustments (Net Income) | ||||||
3rd Quarter 2020 Non-GAAP Net Income | ||||||
3rd Quarter 2020 Non-GAAP Operating Income |
(1) | Adjustments relate to amortization of acquired intangibles and stock-based compensation recognized during the periods for GAAP purposes. |
(2) | Adjustments relate to non-recurring items |
(3) | The Company's Non-GAAP tax provision is on the basis of the Q3 2020 effective tax rate, which reflects currently available information and could be subject to change. |
Non-GAAP Financial Measures and Other Metrics
This press release contains the following non-GAAP financial measures: non-GAAP net income (loss), non-GAAP operating income and non-GAAP Earnings per share. Non-GAAP operating income (loss), non-GAAP net income (loss) and non-GAAP EPS from operations exclude amortization of intangibles and stock-based compensation. Non-GAAP operating income (loss), non-GAAP net income (loss) and non-GAAP EPS from operations can also exclude the effect of any restructuring, acquisition, integration & other expenses, legal expenses associated with such acquisitions or legal expenses associated with non-operating activities, or any one-time tax benefits.
Ebix believes that these non-GAAP financial measures and other metrics provide useful information to management and investors regarding certain financial and business trends relating to Ebix’s financial condition and results of operations. The Company’s management uses these non-GAAP measures and other metrics to compare the Company’s performance to that of prior periods for trend analysis, for purposes of determining executive and senior management incentive compensation, and for budgeting and planning purposes. The Company believes that the use of these non-GAAP financial measures and other metrics provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing the Company’s financial measures with other software companies, many of which present similar non-GAAP financial measures and other metrics to investors.
Management of the Company does not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company’s financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. Ebix urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including the financial tables at the end of this press release, and not to rely on any single financial measure to evaluate the Company’s business.
Conference Call Details:
Call Date/Time: | Monday, November 9, 2020 at 11:00 a.m. EST |
Call Dial-In: | +1-877-837-3909 or 1-973-409-9690; Call ID # 6782823 |
Live Audio Webcast: | www.ebix.com/webcast or https://edge.media-server.com/mmc/p/bkzs93gs |
Audio Replay URL: | www.ebix.com/result_20_Q3 after 2:00 p.m. EST on Nov 9th |
About Ebix, Inc.
With 50+ offices across 6 continents, Ebix, Inc., (NASDAQ: EBIX) endeavors to provide On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries. In the Insurance sector, Ebix’s main focus is to develop and deploy a wide variety of insurance and reinsurance exchanges on an on-demand basis, while also providing Software-as-a-Service ("SaaS") enterprise solutions globally in the area of CRM, front-end & back-end systems, outsourced administration and risk compliance services.
With a "Phygital” strategy that combines 320,000 physical distribution outlets in many Southeast Asian Nations (“ASEAN”) countries, to an Omni-channel online digital platform, the Company’s EbixCash Financial exchange portfolio encompasses leadership in the areas of domestic & international money remittance, foreign exchange (Forex), travel, pre-paid & gift cards, utility payments, and lending, wealth and asset management solutions and services in India and other markets. EbixCash’s Forex operations have emerged as a leader in India’s airport Foreign Exchange business, with operations in 32 international airports, including Delhi, Mumbai, Bangalore, Hyderabad, Chennai and Kolkata. These Forex operations conduct over
Through its various SaaS-based software platforms, Ebix employs thousands of domain-specific technology professionals to provide products, support and consultancy to thousands of customers on six continents. For more information, visit the Company’s website at www.ebix.com
SAFE HARBOR REGARDING FORWARD-LOOKING STATEMENTS
As used herein, the terms “Ebix,” “the Company,” “we,” “our” and “us” refer to Ebix, Inc., a Delaware corporation, and its consolidated subsidiaries as a combined entity, except where it is clear that the terms mean only Ebix, Inc.
The information contained in this Press Release contains forward-looking statements and information within the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. This information includes assumptions made by, and information currently available to management, including statements regarding future economic performance and financial condition, liquidity and capital resources, acceptance of the Company's products by the market, and management's plans and objectives. In addition, certain statements included in this and our future filings with the Securities and Exchange Commission ("SEC"), in press releases, and in oral and written statements made by us or with our approval, which are not statements of historical fact, are forward-looking statements. Words such as "may," "could," "should," "would," "believe," "expect," "anticipate," "estimate," "intend," "seeks," "plan," "project," "continue," "predict," "will," "should," and other words or expressions of similar meaning are intended by the Company to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are found at various places throughout this report and in the documents incorporated herein by reference. These statements are based on our current expectations about future events or results and information that is currently available to us, involve assumptions, risks, and uncertainties, and speak only as of the date on which such statements are made.
Our actual results may differ materially from those expressed or implied in these forward-looking statements. Factors that may cause such a difference, include, but are not limited to those discussed in our Annual Report on Form 10-K and subsequent reports filed with the SEC, as well as: the ongoing effects of the Covid-19 global pandemic, the risk of an unfavorable outcome of the pending governmental investigations or shareholder class action lawsuits, reputational harm caused by such investigations and lawsuits, the willingness of independent insurance agencies to outsource their computer and other processing needs to third parties; pricing and other competitive pressures and the Company's ability to gain or maintain share of sales as a result of actions by competitors and others; changes in estimates in critical accounting judgments; changes in or failure to comply with laws and regulations, including accounting standards, taxation requirements (including tax rate changes, new tax laws and revised tax interpretations) in domestic or foreign jurisdictions; exchange rate fluctuations and other risks associated with investments and operations in foreign countries (particularly in Australia, UK and India wherein we have significant operations); equity markets, including market disruptions and significant interest rate fluctuations, which may impede our access to, or increase the cost of, external financing; and international conflict, including terrorist acts.
Except as expressly required by the federal securities laws, the Company undertakes no obligation to update any such factors, or to publicly announce the results of, or changes to any of the forward-looking statements contained herein to reflect future events, developments, changed circumstances, or for any other reason.
Readers should carefully review the disclosures and the risk factors described in the documents we file from time to time with the SEC, including future reports on Forms 10-Q and 8-K, and any amendments thereto.
You may obtain our SEC filings at our website, www.ebix.com under the "Investor Information" section, or over the Internet at the SEC's web site, www.sec.gov.
CONTACT:
Darren Joseph
678 -281-2027 or IR@ebix.com
David Collins or Chris Eddy
Catalyst Global - 212-924-9800 or ebix@catalyst-ir.com
Ebix, Inc. and Subsidiaries Condensed Consolidated Statements of Income (In thousands, except per share data) (Unaudited) | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||
Operating revenue | $ | 154,305 | $ | 147,233 | $ | 403,493 | $ | 434,432 | ||||||||
Operating expenses: | ||||||||||||||||
Cost of services provided | 85,976 | 55,171 | 192,526 | 152,054 | ||||||||||||
Product development | 8,775 | 11,245 | 26,530 | 33,884 | ||||||||||||
Sales and marketing | 3,375 | 4,284 | 10,637 | 14,898 | ||||||||||||
General and administrative, net | 20,888 | 46,900 | 65,596 | 101,210 | ||||||||||||
Amortization and depreciation | 3,392 | 3,626 | 10,142 | 10,966 | ||||||||||||
Total operating expenses | 122,406 | 121,226 | 305,431 | 313,012 | ||||||||||||
Operating income | 31,899 | 26,007 | 98,062 | 121,420 | ||||||||||||
Interest income | 29 | 99 | 112 | 578 | ||||||||||||
Interest expense | (7,495 | ) | (10,970 | ) | (23,879 | ) | (32,551 | ) | ||||||||
Non-operating (loss) income | (4 | ) | 352 | 95 | 344 | |||||||||||
Non-operating expense | — | — | — | (21,140 | ) | |||||||||||
Foreign currency exchange gain | (597 | ) | (641 | ) | 112 | (495 | ) | |||||||||
Income before income taxes | 23,832 | 14,847 | 74,502 | 68,156 | ||||||||||||
Income tax (expense) benefit | 152 | 217 | (2,809 | ) | 297 | |||||||||||
Net income including noncontrolling interest | 23,984 | 15,064 | 71,693 | 68,453 | ||||||||||||
Net loss attributable to noncontrolling interest | (698 | ) | (5,445 | ) | (1,187 | ) | (6,617 | ) | ||||||||
Net income attributable to Ebix, Inc. | $ | 24,682 | $ | 20,509 | $ | 72,880 | $ | 75,070 | ||||||||
Basic earnings per common share attributable to Ebix, Inc. | $ | 0.81 | $ | 0.67 | $ | 2.39 | $ | 2.46 | ||||||||
Diluted earnings per common share attributable to Ebix, Inc. | $ | 0.80 | $ | 0.67 | $ | 2.37 | $ | 2.45 | ||||||||
Basic weighted average shares outstanding | 30,525 | 30,501 | 30,502 | 30,517 | ||||||||||||
Diluted weighted average shares outstanding | 30,853 | 30,633 | 30,748 | 30,598 |
Ebix, Inc. and Subsidiaries Condensed Consolidated Balance Sheets (In thousands, except share amounts) | |||||||
September 30, 2020 | December 31, 2019 | ||||||
ASSETS | (Unaudited) | ||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 88,023 | $ | 73,228 | |||
Receivables from service providers | 19,758 | 25,607 | |||||
Short-term investments | 24,522 | 4,443 | |||||
Restricted cash | 7,902 | 35,051 | |||||
Fiduciary funds - restricted | 4,757 | 4,966 | |||||
Trade accounts receivable, less allowances of | 132,089 | 153,565 | |||||
Other current assets | 69,917 | 67,074 | |||||
Total current assets | 346,968 | 363,934 | |||||
Property and equipment, net | 48,525 | 48,421 | |||||
Right-of-use assets | 13,604 | 19,544 | |||||
Goodwill | 938,680 | 952,404 | |||||
Intangibles, net | 52,864 | 46,955 | |||||
Indefinite-lived intangibles | 27,815 | 42,055 | |||||
Capitalized software development costs, net | 20,420 | 19,183 | |||||
Deferred tax asset, net | 66,992 | 69,227 | |||||
Other assets | 34,682 | 29,896 | |||||
Total assets | $ | 1,550,550 | $ | 1,591,619 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable and accrued liabilities | $ | 68,941 | $ | 84,735 | |||
Payables to service agents | 8,224 | 12,196 | |||||
Accrued payroll and related benefits | 12,079 | 8,755 | |||||
Working capital facility | 7,546 | 28,352 | |||||
Fiduciary funds - restricted | 4,757 | 4,966 | |||||
Short-term debt | 8,349 | 1,167 | |||||
Contingent liability for accrued earn-out acquisition consideration | 3,352 | 8,621 | |||||
Current portion of long term debt and financing lease obligations, net of deferred financing costs of | 23,620 | 22,091 | |||||
Contract liabilities | 27,807 | 28,712 | |||||
Lease liability | 4,392 | 5,955 | |||||
Other current liabilities | 29,341 | 29,335 | |||||
Total current liabilities | 198,408 | 234,885 | |||||
Revolving line of credit | 439,402 | 438,037 | |||||
Long term debt and financing lease obligations, less current portion, net of deferred financing costs of | 237,608 | 254,467 | |||||
Contingent liability for accrued earn-out acquisition consideration | — | 1,474 | |||||
Contract liabilities | 7,474 | 8,541 | |||||
Lease liability | 9,128 | 13,196 | |||||
Deferred tax liability, net | 1,235 | 1,235 | |||||
Other liabilities | 26,725 | 40,339 | |||||
Total liabilities | 919,980 | 992,174 | |||||
Stockholders’ equity: | |||||||
Preferred stock, outstanding at June September 30, 2020 and December 31, 2019 | — | — | |||||
Series Y Convertible preferred stock, issued and outstanding at September 30, 2020 and no shares authorized, issue and outstanding at December 31, 2019 | — | — | |||||
Common stock, outstanding, at September 30, 2020, and 30,492,044 issued and outstanding at December 31, 2019 | 3,053 | 3,049 | |||||
Additional paid-in capital | 10,537 | 6,960 | |||||
Retained earnings | 683,131 | 618,503 | |||||
Accumulated other comprehensive loss | (114,295 | ) | (78,398 | ) | |||
Total Ebix, Inc. stockholders’ equity | 582,426 | 550,114 | |||||
Noncontrolling interest | 48,144 | 49,331 | |||||
Total stockholders’ equity | 630,570 | 599,445 | |||||
Total liabilities and stockholders’ equity | $ | 1,550,550 | $ | 1,591,619 |
Ebix, Inc. and Subsidiaries Condensed Consolidated Statements of Cash Flows (In thousands) (Unaudited) | |||||||
Nine Months Ended | |||||||
September 30, | |||||||
2020 | 2019 | ||||||
Cash flows from operating activities: | |||||||
Net income attributable to Ebix, Inc. | $ | 72,880 | $ | 75,070 | |||
Net loss attributable to noncontrolling interest | (1,187 | ) | (6,617 | ) | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Amortization and depreciation | 10,142 | 10,966 | |||||
Provision (benefit) for deferred taxes | 987 | (5,880 | ) | ||||
Share based compensation | 3,457 | 2,451 | |||||
Benefit for doubtful accounts | 424 | 10,580 | |||||
Amortization of right-of-use assets | 4,644 | 5,167 | |||||
Unrealized foreign exchange loss | — | 321 | |||||
Amortization of capitalized software development costs | 2,493 | 1,931 | |||||
Reduction of acquisition accruals | (3,308 | ) | (17,124 | ) | |||
Cash paid for acquisition earn-out | (2,881 | ) | — | ||||
Changes in assets and liabilities, net of effects from acquisitions: | |||||||
Accounts receivable | 13,999 | (22,052 | ) | ||||
Receivables from service providers | 5,849 | 9,012 | |||||
Payables to service agents | (3,972 | ) | (12,688 | ) | |||
Other assets | (7,988 | ) | (5,947 | ) | |||
Accounts payable and accrued expenses | (10,620 | ) | (4,062 | ) | |||
Accrued payroll and related benefits | 3,316 | (607 | ) | ||||
Contract liabilities | (1,591 | ) | (9,126 | ) | |||
Lease liabilities | (4,317 | ) | (5,056 | ) | |||
Other liabilities | (10,563 | ) | 33,844 | ||||
Net cash provided by operating activities | 71,764 | 60,183 | |||||
Cash flows from investing activities: | |||||||
Cash paid for acquisitions, net of cash acquired | (12,480 | ) | (104,026 | ) | |||
Cash paid to from Paul Merchants for | — | (4,925 | ) | ||||
Capitalized software development costs | (4,617 | ) | (4,126 | ) | |||
(Purchases) maturities of marketable securities | (20,609 | ) | 25,686 | ||||
Capital expenditures | (1,464 | ) | (5,869 | ) | |||
Net cash used in investing activities | (39,170 | ) | (93,260 | ) | |||
Cash flows from financing activities: | |||||||
Proceeds from revolving line of credit, net | 1,364 | 13,500 | |||||
Principal payments of term loan obligation | (15,063 | ) | (11,298 | ) | |||
Repurchases of common stock | — | (12,952 | ) | ||||
Proceeds from the exercise of stock options | 636 | — | |||||
Forfeiture of certain shares to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vested | (1,841 | ) | (36 | ) | |||
Dividend payments | (6,923 | ) | (6,898 | ) | |||
Payments on short-term notes, net | — | 6,023 | |||||
of debt obligations | 7,187 | (962 | ) | ||||
(Payments) proceeds of working capital facility, net | (19,945 | ) | 31,120 | ||||
Payments of financing lease obligations | (158 | ) | (200 | ) | |||
Net cash (used) provided by financing activities | (34,743 | ) | 18,297 | ||||
Effect of foreign exchange rates on cash | (7,222 | ) | (2,397 | ) | |||
Net change in cash and cash equivalents, and restricted cash | (9,371 | ) | (17,177 | ) | |||
Cash and cash equivalents, and restricted cash at the beginning of the period | 111,369 | 149,681 | |||||
Cash and cash equivalents, and restricted cash at the end of the period | $ | 101,998 | $ | 132,504 | |||
Supplemental disclosures of cash flow information: | |||||||
Interest paid | $ | 22,237 | $ | 31,787 | |||
Income taxes paid | $ | 8,019 | $ | 7,406 |
FAQ
What were Ebix's Q3 2020 earnings results?
How did COVID-19 affect Ebix's business in Q3 2020?
What is Ebix's cash flow situation as of Q3 2020?